CMV DNA synthesis and late viral gene expression

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 295-310

  Anders, David G ^a   Kerry, Julie A ^b   Pari, Gregory S ^c  

^a WADSWORTH CENTER   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929295980     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.020     Document Type: Chapter

References (149)

1. Anders, D. G. and Gibson, W. (1988). Location, transcript analysis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similarities to ICP8 of herpes simplex virus type 1. J. Virol., 62(4), 1364-1372.
2. Anders, D. G. and McCue, L. A. (1996). The human cytomegalovirus genes and proteins required for DNA synthesis. Intervirology, 39(5-6), 378-388.
3. Anders, D. G. and Punturieri, S. M. (1991). Multicomponent origin of cytomegalovirus lytic-phase DNA replication. J. Virol., 65(2), 931-937.
4. Anders, D. G., Irmiere, A., and Gibson, W. (1986). Identification and characterization of na major early cytomegalovirus DNA-binding protein. J. Virol., 58(2), 253-262.
5. Anders, D. G., Kidd, J. R., and Gibson, W. (1987). Immunologi-cal characterization of an early cytomegalovirus single-strand DNA-binding protein with similarities to the HSV major DNA-binding protein. Virology, 161(2), 579-588.
6. Anders, D. G., Kacica, M. A., Pari, G. S., and Punturieri, S. M. (1992). Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J. Virol., 66(6), 3373-3384.
7. Arumugaswami, V., Wu, T. T., Martinez-Guzman, D. et al. (2006). ORF18 is a transfactor that is essential for late gene transcrip-tion of a gammaherpesvirus. J. Virol., 80(19), 9730-9740.
8. Boehmer, P. E. (2004). RNA binding and R-loop formation by the herpes single-stranded DNA-binding protein (ICP8). Nucl. Acids Res, 32(15), 4576-4584.
9. Boehmer, P. E. and Lehman, I. R. (1993a). Herpes simplex virus type 1 ICP8: Helix-destabilizing properties. J. Virol., 67(2), 711-5.
10. Boehmer, P. E. and Lehman, I. R. (1993b). Physical interaction between the herpes simplex virus 1 origin-binding protein and single-stranded DNA-binding pro-tein ICP8. Proc. Natl Acad. Sci. USA, 90(18), 8444-8448.
11. Boehmer, P. E., Dodson, M. S., and Lehman, I. R. (1993). The her-pes simplex virus type-1 origin binding protein. DNA helicase activity. J. Biol. Chem., 268(2), 1220-5.
12. Bolovan-Fritts, C. A., Mocarski, E. S., and Wiedeman, J. A. (1999). Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood, 93(1), 394-398.
13. Borst, E. M. and Messerle, M. (2005). Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J. Virol., 79(6), 3615-3626.
14. Bruckner, R. C., Crute, J. J., Dodson, M. S., and Lehman, I. R. (1991). The herpes simplex virus 1 origin binding protein: A DNA heli-case. J. Biol. Chem., 266, 2669-2674.
15. Chambers, J., Angulo, A., Amaratunga, D. etal.(1999). DNAmicroar-rays of the complex human cytomegalovirus genome: Pro?l-ing kinetic class with drug sensitivity of viral gene expression. J. Virol., 73(7), 5757-5766.
16. Chiou, C. J., Zong, J., Waheed, I., and Hayward, G. S. (1993). Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus. J. Virol., 67(10), 6201-6214.
17. Chiou, H. C., Weller, S. K., and Coen, D. M. (1985). Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors. Virology, 145(2), 213-226.
18. Cihlar, T., Fuller, M. D., and Cherrington, J. M. (1997). Expres-sion of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a cou-pled in vitro transcription/translation system. Protein Expr. Purif., 11(2), 209-218.
19. Cihlar, T., Fuller, M. D., and Cherrington, J. M. (1998a). Characteri-zation of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. J. Virol., 72(7), 5927-5936.
20. Cihlar, T., Fuller, M. D., Mulato, A. S., and Cherrington, J. M. (1998b). A point mutation in the human cytomegalovirus DNA poly-merase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture. Virology, 248(2), 382-393.
21. Coen, D. M. (1996). Viral DNA polymerases. In DNA Replication in Eukaryotic Cells ed. (D. ML, Ed.), pp. 495-523. Cold Spring Harbor: Cold Spring Harbor Press.
22. Colberg-Poley, A. M. (1996). Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci. Intervirology, 39(5-6), 350-360.
23. Colberg-Poley, A. M., Santomenna, L. D., Harlow, P. P., Ben?eld, P. A., and Tenney, D. J. (1992). Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J. Virol., 66(1), 95-105.
24. Colberg-Poley, A. M., Huang, L., Soltero, V. E., Iskenderian, A. C., Schumacher, R. F. and Anders, D. G. (1998). The acidic domain of pUL371 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions. Virol-ogy, 246(2), 400-408.
25. Colletti, K. S., Xu, Y., Cei, S. A., Tarrant, M., and Pari, G. S. (2004). Human cytomegalovirus UL84 oligomerization and act as transdominant inhibitors of oriLyt-evidence that IE2-UL84 and UL84-UL84 interactions DNA replication. J. Virol., 78(17), 9203-9214.
26. Colletti, K. S., Yu, Y., Yamboliev, I., and Pari, G. S. (2005). Human cytomegalovirus UL84 is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H Box family of proteins. J. Biol. Chem. (in press)
27. Davison, A. J., Dolan, A., Akter, P. et al. (2003). The human cytomegalovirus genome revisited: Comparison with the chim-panzee cytomegalovirus genome. J. Gen. Virol., 84(1), 17-28.
28. DeMeritt, I. B., Podduturi, J. P., Tilley, A. M., Nogalski, M. T., and Yurochko, A. D. (2006). Prolonged activation of NF-KB by human cytomegalovirus promotes ef?cient viral replication and late gene expression. Virology, 346(1), 15-31.
29. Depto, A. S. and Stenberg, R. M. (1989). Regulated expression of the human cytomegalovirus pp65 gene: Octamer sequence in the promoter is required for activation by viral gene products. J. Virol., 63(3), 1232-1238.
30. Depto, A. S. and Stenberg, R. M. (1992). Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: Cis-acting elements and viral trans-acting proteins necessary for promoter activation. J. Virol., 66(5), 3241-3246.
31. Dewhurst, S., Dollard, S. C., Pellett, P. E., and Dambaugh, T. R. (1993). Identification of a lytic-phase origin of DNA replica-tion in human herpesvirus 6B strain Z29. J. Virol., 67(12), 7680-7683.
32. Dewhurst, S., Krenitsky, D. M., and Dykes, C. (1994). Human her-pesvirus 6B origin: Sequence diversity, requirement for two binding sites for origin-binding protein, and enhanced repli-cation from origin multimers. J. Virol., 68(10), 6799-6803.
33. Dracheva, S., Koonin, E. V., and Crute, J. J. (1995). Identification of the primase active site of the herpes simplex virus type 1 helicase-primase. J. Biol. Chem., 270(23), 14148-14153.
34. Dunn, W., Chou, C., Li, H. et al. (2003). Functional pro?ling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA, 100(24), 14223-14228. Epub 2003 Nov 17.
35. Dutch, R. E. and Lehman, I. R. (1993). Renaturation of complemen-tary DNA strands by herpes simplex virus type 1 ICP8. J. Virol., 67(12), 6945-9.
36. Dykes, C., Chan, H., Krenitsky, D. M., and Dewhurst, S. (1997). Strin-gent structural and sequence requirements of the human her-pesvirus 6B lytic-phase origin of DNA replication. J. Gen. Virol., 78(5), 1125-1129.
37. Eckle, T., Prix, L., Jahn, G. et al. (2000). Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood, 96(9), 3286-3289.
38. Eizuru, Y. (1998). [Analysis of ganciclovir-resistant cytome-galovirus]. Nippon Rinsho, 56(1), 151-155.
39. Ertl, P. F. and Powell, K. L. (1992). Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J. Virol., 66(7), 4126-4133.
40. Falkenberg, M., Bushnell, D. A., Elias, P., and Lehman, I. R. (1997). The UL8 subunit of the heterotrimeric herpes simplex virus type 1 helicase-primase is required for the unwinding of single strand DNA-binding protein (ICP8)-coated DNA substrates. J. Biol. Chem., 272(36), 22766-22770.
41. Fierer, D. S. and Challberg, M. D. (1992). Puri?cation and character-ization of UL9, the herpes simplex virus type 1 origin-binding protein. J. Virol., 66, 3986-3995.
42. Flanagan, W. M., Papavassiliou, A. G., Rice, M., Hecht, L. B., Sil-verstein, S., and Wagner, E. K. (1991). Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. J. Virol., 65(2), 769-786.
43. Freitas, V. R., Smee, D. F., Chernow, M., Boehme, R., and Matthews, T. R. (1985). Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses. Antimicrob. Agents Chemother., 28(2), 240-245.
44. Furnari, B. A., Poma, E., Kowalik, T. F., Huong, S. M., and Huang, E. S. (1993). Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J. Virol., 67(8), 4981-4991.
45. Gebert, S., Schmolke, S., Sorg, G., Floss, S., Plachter, B., and Stam-minger, T. (1997). The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replica-tion. J. Virol., 71(9), 7048-7060.
46. Gibson, W. (1983). Protein counterparts of human and simian cytomegaloviruses. Virology, 128(2), 391-406.
47. Gibson, W. (1984). Synthesis, structure and function of cytomega-lovirus major nonvirion nuclear protein. In Herpesvirus ed. F. Rapp, pp. 423-440. New York: Liss.
48. Gibson, W., Murphy, T. L., and Roby, C. (1981). Cytomegalovirus-infected cells contain a DNA-binding protein. Virology, 111(1), 251-262.
49. Goldmacher, V. S., Bartle, L. M., Skaletskaya, A. (1999). A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA, 96(22), 12536-12541.
50. Hamatake, R. K., Bifano, M., Hurlburt, W. W., and Tenney, D. J. (1997). A functional interaction of ICP8, the herpes simplex virus single-stranded DNA-binding protein, and the helicase-primase complex that is dependent on the presence of the UL8 subunit. J. Gen. Virol., 78 (4), 857-865.
51. Hamzeh, F. M., Lietman, P. S., Gibson, W., and Hayward, G. S. (1990). Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination. J. Virol., 64(12), 6184-6195.
52. Hayajneh, W. A. et al. (2001). The sequence and antiapoptotic func-tional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology, 279(1), 233-240.
53. Hazuda, D. J., Perry, H. C., Naylor, A. M., and McClements, W. L. (1991). Characterization of the herpes simplex virus origin binding protein interaction with oris. J. Biol. Chem., 266(36), 24621-24626.
54. He, Y. S., Xu, L., and Huang, E. S. (1992). Characterization of human cytomegalovirus UL84 early gene and Identification of its puta-tive protein product. J. Virol., 66(2), 1098-1108.
55. Heider, J. A., Bresnahan, W. A., and Shenk, T. E. (2002). Construc-tion of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc. Natl Acad. Sci. USA, 99(5), 3141-3146.
56. Herendeen, D. R., Kassavetis, G. A., Barry, J., Alberts, B. M., and Geiduschek, E. P. (1989). Enhancement of bacteriophage T4 late transcription by components of the T4 DNA replication apparatus. Science, 245(4921), 952-958.
57. Herendeen, D. R., Kassavetis, G. A., and Geiduschek, E. P. (1992). A transcriptional enhancer whose function imposes a require-ment that proteins track along DNA. Science, 256(5061), 1298-1303.
58. Hernandez, T. R. and Lehman, I. R. (1990). Functional interaction between the herpes simplex-1 DNA polymerase and UL42 pro-tein. J. Biol. Chem., 265(19), 11227-11232.
59. Ho, M. (1991). Cytomegalovirus: Biology and Infection. 2nd edn. New York: Plenum Publishing Corporation.
60. Hofmann, H., Floss, S., and Stamminger, T. (2000). Covalent modi?cation of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J. Virol., 74(6), 2510-2524.
61. Homa, F. L., Otal, T. M., Glorioso, J. C., and Levine, M. (1986). Tran-scriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases-34 to +124 relative to the 5? terminus of the mRNA. Mol. Cell Biol., 6(11), 3652-3666.
62. Huang, E. S. (1975). Human cytomegalovirus. III. Virus-induced DNA polymerase. J. Virol., 16(2), 298-310.
63. Huang, L., Zhu, Y., and Anders, D. G. (1996). The variable 3? ends of a human cytomegalovirus oriLyt transcript (SRT) overlap an essential, conserved replicator element. J. Virol., 70(8), 5272-5281.
64. Ilyina, T. V., Gorbalenya, A. E., and Koonin, E. V. (1992). Organiza-tion and evolution of bacterial and bacteriophage primase-helicase systems. J. Mol. Evol., 34(4), 351-357.
65. Inoue, N. and Pellett, P. E. (1995). Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence. J. Virol., 69(8), 4619-4627.
66. Inoue, N., Dambaugh, T. R., Rapp, J. C., and Pellett, P. E. (1994). Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses. J. Virol., 68(7), 4126-4136.
67. Jackson, S. A. and DeLuca, N. A. (2003). Relationship of herpes sim-plex virus genome con?guration to productive and persistent infections. Proc. Natl Acad. Sci. USA, 100(13), 7871-7876. Epub 2003 Jun 9.
68. Jenkins, D. E., Martens, C. L., and Mocarski, E. S. (1994). Human cytomegalovirus late protein encoded by ie2: A trans-activator as well as a repressor of gene expression. J. Gen. Virol., 75(9), 2337-2348.
69. Jones, T. R. and Muzithras, V. P. (1991). Fine mapping of transcripts expressed from the cytomegalovirus strain AD169. J. Virol., 65(4), 2024-2036.
70. Kemble, G. W., McCormick, A. L., Pereira, L., and Mocarski, E. S. (1987). A cytomegalovirus protein with properties of herpes simplex virus ICP8: Partial puri?cation of the polypeptide and map position of the gene. J. Virol., 61(10), 3143-3151.
71. Kerry, J. A., Priddy, M. A., Jervey, T. Y. et al. (1996). Multiple reg-ulatory events in?uence human cytomegalovirus DNA poly-merase (UL54) expression during viral infection. J. Virol., 70(1), 373-382.
72. Kerry, J. A., Priddy, M. A., Kohler, C. P. et al. (1997). Translational reg-ulation of the human cytomegalovirus pp28 (UL99) late gene. J. Virol., 71(2), 981-987.
73. Kiehl, A., Huang, L., Franchi, D., and Anders, D. G. (2003). Multiple 5 ends of human cytomegalovirus UL57 transcripts identify a complex, cycloheximide-resistant promoter region that acti-vates oriLyt. Virology, 314(1), 410-422.
74. Kohler, C. P., Kerry, J. A., Carter, M., Muzithras, V. P., Jones, T. R., and Stenberg, R. M. (1994). Use of recombinant virus to assess human cytomegalovirus early and late promoters in the con-text of the viral genome. J. Virol., 68(10), 6589-6597.
75. Kouzarides, T., Bankier, A. T., Satchwell, S. C., Preddy, E., and Barrell, B. G. (1988). An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein. Virology, 165(1), 151-164.
76. Krosky, P. M., Baek, M. C., Jahng, W. J. et al. (2003). The human cytomegalovirus UL44 protein is a substrate for the UL97 pro-tein kinase. J. Virol., 77(14), 7720-7727.
77. Krug, L. T., Inoue, N., and Pellett, P. E. (2001). Sequence require-ments for interaction of human herpesvirus 7 origin binding protein with the origin of lytic replication. J. Virol., 75(8), 3925-3936.
78. Lang, D., Gebert, S., Arlt, H., and Stamminger, T. (1995). Func-tional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J. Virol., 69(10), 6030-6037.
79. Leach, F. S. and Mocarski, E. S. (1989). Regulation of cytomegalovirus late-gene expression: Differential use of three start sites in the transcriptional activation of ICP36 gene expression. J. Virol., 63(4), 1783-1791.
80. Leatham, M. P., Witte, P. R., and Stinski, M. F. (1991). Alternate pro-moter selection within a human cytomegalovirus immediate-early and early transcription unit (UL119-115) de?nes true late transcripts containing open reading frames for putative viral glycoproteins. J. Virol., 65(11), 6144-6153.
81. Lee, C. K. and Knipe, D. M. (1985). An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J. Virol., 54(3), 731-738.
82. Lee, J. M., Kang, H. J., Lee, H. R., Choi, C. Y., Jang, W. J., and Ahn, J. H. (2003). PIAS1 enhances SUMO-1 modi?cation and the major immediate-early IE2 protein of human. FEBS Lett., 555(2), 322-328.
83. Li, R., Yang, L., Fouts, E., and Botchan, M. R. (1993). Site-speci?c DNA-binding proteins important for replication and tran-scription have multiple activities. Cold Spring Harb. Symp. Quant. Biol., 58, 403-413.
84. Lischka, P., Sorg, G., Kann, M., Winkler, M., and Stamminger, T. (2003). A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin alpha/beta pathway. J. Virol., 77(6), 3734-3748.
85. Loregian, A., Rigatti, R., Murphy, M., Schievano, E., Palu, G., and Marsden, H. S. (2003). Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 sub-unit. J. Virol., 77(15), 8336-8344.
86. Loregian, A., Appleton, B. A., Hogle, J. M., and Coen, D. M. (2004). Residues of human cytomegalovirus DNA polymerase cata-lytic subunit UL54 that are necessary and suf?cient for interac-tion with the accessory protein UL44. J. Virol., 78(1), 158-167.
87. Lukac, D. M., Manuppello, J. R., and Alwine, J. C. (1994). Transcrip-tional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcrip-tion complex. J. Virol., 68(8), 5184-5193
88. Marchini, A., Liu, H., and Zhu, H. (2001). Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol., 75(4), 1870-1878.
89. Masse, M. J., Karlin, S., Schachtel, G. A., and Mocarski, E. S. (1992). Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA, 89(12), 5246-5250.
90. Masse, M. J., Messerle, M., and Mocarski, E. S. (1997). The loca-tionandsequencecompositionofthemurinecytomegalovirus replicator (oriLyt). Virology, 230(2), 350-360.
91. McCormick, L., Igarashi, K., and Roizman, B. (1999). Posttranscrip-tional regulation of US11 in cells infected with a herpes simplex virus 1 recombinant lacking both 222-bp domains containing S-component origins of DNA synthesis. Virology, 259(2), 286-298.
92. McMahon, T. P. and Anders, D. G. (2002). Interactions between human cytomegalovirus helicase-primase proteins. Virus Res., 86(1-2), 39-52.
93. McVoy, M. A. and Adler, S. P. (1994). Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J. Virol., 68(2), 1040-1051.
94. McWatters, B. J., Stenberg, R. M., and Kerry, J. A. (2002). Character-ization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. Virology, 303(2), 309-316.
95. Menegazzi, P., Galvan, M., Rotola, A. et al. (1999). Temporal map-ping of transcripts in human herpesvirus-7. J. Gen. Virol., 80 (10), 2705-2712.
96. Mirandola, P., Menegazzi, P., Merighi, S., Ravaioli, T., Cassai, E., and Di Luca, D. (1998). Temporal mapping of transcripts in her-pesvirus 6 variants. J. Virol., 72(5), 3837-3844.
97. Mocarski, E. J. and Courcelle, CT., (2001). Cytomegaloviruses and their replication. In Fields Virology 4th edn. ed. D. M. Knipe, P. M. Howley, D. E. Grif?n et al. Vol. 2, pp. 2629-2673. 2 vols. Philadelphia, PA: Lippincott Williams & Wilkins.
98. Mocarski, E. S., Pereira, L., and Michael, N. (1985). Precise localiza-tion of genes on large animal virus genomes: Use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc. Natl Acad. Sci. USA, 82(4), 1266-1270.
99. Morello, C. S., Ye, M., and Spector, D. H. (2002). Development of a vaccine against murine cytomegalovirus (MCMV), consist-ing of plasmid DNA and formalin-inactivated MCMV, that pro-vides long-term, complete protection against viral replication. J. Virol., 76, 4822-4835.
100. Mousavi-Jazi, M., Hokeberg, I., Schloss, L. et al. (2001). Sequence analysis of UL54 and UL97 genes and evaluation of antivi-ral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment. Transpl. Infect. Dis., 3(4), 195-202.
101. Mousavi-Jazi, M., Schloss, L., Wahren, B., and Brytting, M. (2003). Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase. J. Clin. Virol., 26(3), 301-306.
102. Murphy, E., Rigoutsos, I., Shibuya, T., and Shenk, T. E. (2003a). Reevaluation of human cytomegalovirus coding potential. Proc. Natl Acad. Sci. USA, 100(23), 13585-13590. Epub 2003 Oct 30.
103. Murphy, E., Yu, D., Grimwood, J. et al. (2003b). Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl Acad. Sci. USA, 100(25), 14976-14981. Epub 2003 Dec 1.
104. Olivo, P. D., Nelson, N. J., and Challberg, M. D. (1988). Herpes simplex virus DNA replication: The UL9 gene encodes an origin-binding protein. Proc. Natl Acad. Sci. USA, 85(15), 5414-5418.
105. Pari, G. S. and Anders, D. G. (1993). Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol., 67(12), 6979-6988.
106. Penfold, M. E. and Mocarski, E. S. (1997). Formation of cytomegalovirus DNA replication compartments de?ned by localization of viral proteins and DNA synthesis. Virology, 239(1), 46-61.
107. Perkins, K. D., Gregonis, J., Borge, S., and Rice, S. A. (2003). Transactivation of a viral target gene by herpes simplex virus ICP27 is posttranscriptional and does not require the endoge-nous promoter or polyadenylation site. J. Virol., 77(18), 9872-9884.
108. Plachter, B., Britt, W., Vornhagen, R., Stamminger, T., and Jahn, G. (1993). Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies gen-erated against recombinant antigens. Virology, 193(2), 642-652.
109. Prichard, M. N., Jairath, S., Penfold, M. E., St Jeor, S., Bohlman, M. C., and Pari, G. S. (1998). Identification of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol., 72(9), 6997-7004.
110. Puchtler, E. and Stamminger, T. (1991). An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infec-tion. J. Virol., 65(11), 6301-6306.
111. Reboredo, M., Greaves, R. F., and Hahn, G. (2004). Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected ?broblasts against virus-induced apoptosis and are required for ef?cient virus replication. J. Gen. Virol., 85, 3555-3567.
112. Reid, G. G., Ellsmore, V., and Stow, N. D. (2003). An analysis of the requirements for human cytomegalovirus oriLyt-dependent DNA synthesis in the presence of the herpes simplex virus type 1 replication fork proteins. Virology, 308(2), 303-316.
113. Reuven, N. B., Willcox, S., Grif?th, J. D., and Weller, S. K. (2004). Catalysis of strand exchange by the HSV-1 UL12 ICP8 recom-binase activity is revealed upon nuclease. J. Mol. Biol., 342(1), 57-71.
114. Ripalti, A., Boccuni, M. C., Campanini, F., and Landini, M. P. (1995). Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astro-cytoma cell line: Identification of an essential gene. J. Virol., 69, 2047-2057.
115. Romanowski, M. J. and Shenk, T. (1997). Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol., 71(2), 1485-1496.
116. Rudolph, S. A., Stamminger, T., and Jahn, G. (1990). Transcriptional analysis of the eight-kilobase mRNA encoding the major cap-sid protein of human cytomegalovirus. J. Virol., 64(10), 5167-5172.
117. Ruyechan, W. T. (1983). The major herpes simplex virus DNA-binding protein holds single-stranded DNA in an extended con?guration. J. Virol., 46(2), 661-666.
118. Samaniego, L. A., Tevethia, M. J., and Spector, D. J. (1994). The human cytomegalovirus 86-kilodalton immediate-early 2 pro-tein: Synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin. J. Virol., 68(2), 720-729.
119. Sanchez, V., Clark, C. L., Yen, J. Y., Dwarakanath, R., and Spector, D. H. (2002). Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J. Virol., 76(6), 2973-2989.
120. Sarisky, R. T. and Hayward, G. S. (1996). Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replica-tion compartments in cotransfection assays. J. Virol., 70(11), 7398-7413.
121. Schwartz, R., Helmich, B., and Spector, D. H. (1996). CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J. Virol., 70(10), 6955-6966.
122. Scully, A. L., Sommer, M. H., Schwartz, R., and Spector, D. H. (1995). The human cytomegalovirus IE2 86-kilodalton protein inter-acts with an early gene promoter via site-speci?c DNA binding and protein-protein associations. J. Virol., 69(10), 6533-6540.
123. Severini, A., Sevenhuysen, C., Garbutt, M., and Tipples, G. A. (2003). Structure of replicating intermediates of human herpesvirus type 6. Virology, 314(1), 443-450.
124. Smith, J. A. and Pari, G. S. (1995). Human cytomegalovirus UL102 gene. J. Virol., 69(3), 1734-1740.
125. Smith, J. A., Jairath, S., Crute, J. J., and Pari, G. S. (1996). Char-acterization of the human cytomegalovirus UL105 gene and Identification of the putative helicase protein. Virology, 220(1), 251-255.
126. Spector, D. J. and Tevethia, M. J. (1994). Protein-protein interac-tions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J. Virol., 68(11), 7549-7553.
127. Stamey, F. R., Dominguez, G., Black, J. B., Dambaugh, T. R., and Pel-lett, P. E. (1995). Intragenomic linear ampli?cation of human herpesvirus 6B oriLyt suggests acquisition of oriLyt by trans-position. J. Virol., 69(1), 589-596.
128. Stasiak, P. C. and Mocarski, E. S. (1992). Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J. Virol., 66(2), 1050-1058.
129. Tanguy LeGac, N., Villani, G., and Boehmer, P. E. (1998). Her-pes simplex virus type-1 single-strand DNA-binding protein (ICP8) enhances the ability of the viral DNA helicase-primase to unwind cisplatin-modified DNA. J. Biol. Chem., 273(22), 13801-13807.
130. Tenney, D. J. and Colberg-Poley, A. M. (1991a). Expression of the human cytomegalovirus UL36-38 immediate early region dur-ing permissive infection. Virology, 182(1), 199-210.
131. Tenney, D. J., and Colberg-Poley, A. M. (1991b). Human cytomegalovirus UL36-38 and US3 immediate-early genes: Temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J. Virol., 65(12), 6724-6734.
132. van Loon, N., Dykes, C., Deng, H., Dominguez, G., Nicholas, J., and Dewhurst, S. (1997). Identification and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7. J. Virol., 71(4), 3279-3284.
133. Vink, C., Beuken, E., and Bruggeman, C. A. (1997). Cloning and functional characterization of the origin of lytic-phase DNA replication of rat cytomegalovirus. J. Gen. Virol., 78(11), 2963-2973.
134. Wade, E. J. and Spector, D. H. (1994). The human cytomegalovirus origin of DNA replication (oriLyt) is the critical cis-acting sequence regulating replication-dependent late induction of the viral 1.2-kilobase RNA promoter. J. Virol., 68(10), 6567-6577.
135. Wahren, B., Ruden, U., Gadler, H., Oberg, B., and Eriksson, B. (1985). Activity of the cytomegalovirus genome in the presence of PPi analogs. J. Virol., 56(3), 996-1001.
136. Wara-aswapati, N., Yang, Z., Waterman, W. R. et al. (1999). Cytomegalovirus IE2 protein stimulates interleukin 1beta gene transcription via tethering to Spi-1/PU.1. Mol. Cell Biol., 19(10), 6803-6814.
137. Weir, J. P. (2001). Regulation of herpes simplex virus gene expres-sion. Gene, 271(2), 117-130.
138. White, E. A., Clark, C. L., Sanchez, V., and Spector, D. H. (2004). Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol., 78(4), 1817-1830.
139. Wiebusch, L., Truss, M., and Hagemeier, C. (2004). Inhibition of human cytomegalovirus replication by small interfering RNAs. J. Gen. Virol., 85(1), 179-184.
140. Wilkinson, G. W., Akrigg, A., and Greenaway, P. J. (1984). Transcrip-tion of the immediate early genes of human cytomegalovirus strain AD169. Virus Res., 1(2), 101-106.
141. Wilson, B. J., Bates, G. J., Nicol, S. M., Gregory, D. J., Perkins, N. D., and Fuller-Pace, F. V. (2004). The p68 and p72 DEAD box RNA helicasesinteracttranscriptioninapromoter-speci?cmanner. BMC Mol. Biol., 5(1), 11.
142. Wing, B. A., Johnson, R. A., and Huang, E. S. (1998). Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: Role of IE2-86 and cellular p53 in mediating negative regulatory function. J. Virol., 72(3), 1814-1825.
143. Wu, C. A., Nelson, N. J., McGeoch, D. J., and Challberg, M. D. (1988). Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis. J. Virol., 62(2), 435-443.
144. Wu, J., Oneill, J., and Barbosa, M. S. (2001). Late temporal gene expression from the human cytomegalovirus pp28US (UL99) promoter when integrated into the host cell chromosome. J. Gen. Virol., 82(5), 1147-1155.
145. Xu, Y., Colletti, K. S., and Pari, G. S. (2002). Human cytomegalovirus UL84 localizes to the cell nucleus via a nuclear localization signal and is a component of viral replication compartments. J. Virol., 76(17), 8931-8938.
146. Xu, Y., Cei, S. A., Rodriguez Huete, A., Colletti, K. S., and Pari, G. S. (2004). Human cytomegalovirus DNA replication requires transcriptional activation via an IE2-and UL84-responsive bidirectional promoter element within oriLyt. J. Virol., 78(21), 11664-11677.
147. Yu, D., Silva, M. C., and Shenk, T. (2003). Functional map of human cytomegalovirus AD169 de?ned by global mutational analysis. Proc. Natl Acad. Sci. USA, 100(21), 12396-12401. Epub 2003. Sep 30.
148. Zhang, H., al-Barazi, H. O., and Colberg-Poley, A. M. (1996). The acidic domain of the human cytomegalovirus UL37 immediate early glycoprotein is dispensable for its transactivating activity and localization but is not for its synergism. Virology, 223(2), 292-302.
149. Zhu, Y., Huang, L., and Anders, D. G. (1998). Human cytomegalovirus oriLyt sequence requirements. J. Virol., 72(6), 4989-4996.